Used as a key intermediate in the synthesis of sunitinib, a pharmaceutical agent employed in targeted cancer therapy. It plays a critical role in the development of tyrosine kinase inhibitors, which are designed to block signaling pathways involved in tumor growth and angiogenesis. Due to its structural features, it contributes to the binding affinity and selectivity of the final drug compound toward specific receptor sites. Its application is primarily confined to research and development in oncology drug manufacturing.